nach oben

Erschienen in:

05.12.2016 | Original Article

Spatiotemporal distribution modeling of PET tracer uptake in solid tumors

verfasst von: Madjid Soltani, Mostafa Sefidgar, Hossein Bazmara, Michael E. Casey, Rathan M. Subramaniam, Richard L. Wahl, Arman Rahmim

Erschienen in: Annals of Nuclear Medicine | Ausgabe 2/2017

Einloggen, um Zugang zu erhalten

Abstract

Objective

Distribution of PET tracer uptake is elaborately modeled via a general equation used for solute transport modeling. This model can be used to incorporate various transport parameters of a solid tumor such as hydraulic conductivity of the microvessel wall, transvascular permeability as well as interstitial space parameters. This is especially significant because tracer delivery and drug delivery to solid tumors are determined by similar underlying tumor transport phenomena, and quantifying the former can enable enhanced prediction of the latter.

Methods

We focused on the commonly utilized FDG PET tracer. First, based on a mathematical model of angiogenesis, the capillary network of a solid tumor and normal tissues around it were generated. The coupling mathematical method, which simultaneously solves for blood flow in the capillary network as well as fluid flow in the interstitium, is used to calculate pressure and velocity distributions. Subsequently, a comprehensive spatiotemporal distribution model (SDM) is applied to accurately model distribution of PET tracer uptake, specifically FDG in this work, within solid tumors.

Results

The different transport mechanisms, namely convention and diffusion from vessel to tissue and in tissue, are elaborately calculated across the domain of interest and effect of each parameter on tracer distribution is investigated. The results show the convection terms to have negligible effect on tracer transport and the SDM can be solved after eliminating these terms.

Conclusion

The proposed framework of spatiotemporal modeling for PET tracers can be utilized to comprehensively assess the impact of various parameters on the spatiotemporal distribution of PET tracers.

Wahl R, Buchanan J. Principles and practice of positron emission tomography. Philadelphia: Lippincott Williams & Wilkins; 2002.

Tomasi G, Turkheimer F, Aboagye E. Importance of quantification for the analysis of PET data in oncology: review of current methods and trends for the future. Mol Imaging Biol (Springer-Verlag). 2012;14:131–46.CrossRef

Lodge MA, Lucas JD, Marsden PK, Cronin BF, O’Doherty MJ, Smith MA. A PET study of 18FDG uptake in soft tissue masses. Eur J Nucl Med (Springer-Verlag). 1999;26:22–30.CrossRef

Keyes JW. SUV: standard uptake or silly useless value? J Nucl Med. 1995;36:1836–9.PubMed

Freedman N, Sundaram S, Kurdziel K, Carrasquillo J, Whatley M, Carson J, et al. Comparison of SUV and Patlak slope for monitoring of cancer therapy using serial PET scans. Eur J Nucl Med Mol Imaging (Springer-Verlag). 2003;30:46–53.CrossRef

Young H, Baum R, Cremerius U, Herholz K, Hoekstra O, Lammertsma AA, et al. Measurement of clinical and subclinical tumour response using [18F]-fluorodeoxyglucose and positron emission tomography: review and 1999 EORTC recommendations. Eur J Cancer (Elsevier). 2014;35:1773–82.CrossRef

Huang S-C. Anatomy of SUV. Nucl Med Biol (Pergamon Press). 2000;27:643–6.

Sokoloff L, Reivich M, Kennedy C, Des Rosiers MH, Patlak CS, Pettigrew KD, et al. The [14C] deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure, and normal values in the conscious and anesthetized albino rat 1. J Neurochem (Blackwell Publishing Ltd). 1977;28:897–916.CrossRef

Blomqvist G, Pauli S, Farde L, Ericksson L, Persson A, Halldin C. Clinical research and clinical diagnosis. In: Beckers C, Goffinet A, Bo A, editors. Dyn Model Revers Ligand Bind. New York: Kluwer; 1989.

10.

Sefidgar M, Soltani M, Raahemifar K, Bazmara H, Nayinian S, Bazargan M. Effect of tumor shape, size, and tissue transport properties on drug delivery to solid tumors. J Biol Eng. 2014;8:12.CrossRefPubMedPubMedCentral

11.

Baxter LT, Jain RK. Transport of fluid and macromolecules in tumors III. role of binding and metabolism. Microvasc Res. 1991;41:5–23.CrossRefPubMed

12.

Baxter LT, Jain RK. Transport of fluid and macromolecules in tumors. (I) role of interstitial pressure and convection. Microvasc Res. 1989;37:77–104.CrossRefPubMed

13.

Magdoom KN, Pishko GL, Rice L, Pampo C, Siemann DW, Sarntinoranont M. MRI-based computational model of heterogeneous tracer transport following local infusion into a mouse hind limb tumor. PLoS One. 2014;9:e89594 [cited 2014 Jul 4].CrossRefPubMedPubMedCentral

14.

Pishko GL, Astary GW, Zhang J, Mareci TH, Sarntinoranont M. Role of convection and diffusion on DCE-MRI parameters in low leakiness KHT sarcomas. Microvasc Res (Elsevier Inc). 2012;84:306–13 [cited 2013 Jun 8].CrossRef

15.

Pishko GL, Astary GW, Mareci TH, Sarntinoranont M. Sensitivity analysis of an image-based solid tumor computational model with heterogeneous vasculature and porosity. Ann Biomed Eng. 2011;39:2360–73.CrossRefPubMedPubMedCentral

16.

Stylianopoulos T, Jain RK. Combining two strategies to improve perfusion and drug delivery in solid tumors. PANS. 2013;110:18632–7.CrossRef

17.

Stylianopoulos T, Economides E-A, Baish J, Fukumura D, Jain R. Towards optimal design of cancer nanomedicines: multi-stage nanoparticles for the treatment of solid tumors. Ann Biomed Eng (Springer US). 2015;43:2291–300.CrossRef

18.

Sefidgar M, Soltani M, Raahemifar K, Sadeghi M, Bazmara H, Bazargan M, et al. Numerical modeling of drug delivery in a dynamic solid tumor microvasculature. Microvasc Res. 2015;99:43–56.CrossRefPubMed

19.

Soltani M, Sefidgar M, Bazmara H, Sheikhbahaei S, Marcus C, Ashrafinia S, et al. WE-AB-204-07: spatiotemporal distribution of the FDG PET tracer in solid tumors: contributions of diffusion and convection mechanisms. Med Phys. 2015;42:3660.CrossRef

20.

Soltani M, Sefidgar M, Casey ME, Wahl RL, Subramaniam RM, Rahmim A. Comprehensive Modeling of the Spatiotemporal Distribution of PET Tracer Uptake in Solid Tumors based on the Convection-Diffusion-Reaction Equation. In: 21th IEEE Nuclear Science Symposium Medical imaging Conference Washington State Convention Center, Seattle, WA USA; 2014.

21.

Kelly CJ, Brady M. A model to simulate tumour oxygenation and dynamic [18F] -Fmiso PET data. Phys Med Biol. 2006;51:5859–73.CrossRefPubMed

22.

Monnich D, Troost EGC, Kaanders JHAM, Oyen WJG, Alber M, Thorwarth D. Modelling and simulation of the influence of acute and chronic hypoxia on [18 F] fluoromisonidazole PET imaging. Phys Med Biol. 2012;57:1675–84.CrossRefPubMed

23.

Monnich D, Troost EGC, Kaanders JHAM, Oyen WJG, Alber M, Thorwarth D. Modelling and simulation of [18 F] fluoromisonidazole dynamics based on histology-derived microvessel maps. Phys Med Biol. 2011;56:2045–57.CrossRefPubMed

24.

Alessio A, Bassingthwaighte J, Glenny R, Caldwell J. Validation of an axially distributed model for quantification of myocardial blood flow using 13 N-ammonia PET. J Nucl Cardiol Springer US. 2013;20:64–75.CrossRef

25.

Huang S, Phelps M. Principles of tracer kinetic modeling in positron emission tomography and autoradiography. In: Phelps M, Mazziotta J, Schelbert H, editors. Positron Emission Tomogra Autoradiogram. New York: Raven; 1986. p. 287–346.

26.

Bertoldo A, Peltoniemi P, Oikonen V, Knuuti J, Nuutila P, Cobelli C. Kinetic modeling of [18 F]FDG in skeletal muscle by PET: a four-compartment five-rate-constant model. Am J Physiol Endocrinol Metab. 2001;281:524–36.

27.

Curry FE. Mechanics and thermodynamics of transcapillary exchange. In: Renkin EM, Michel CC, editors. Handb. Physiol, section 2. American Physiological Society; 1984.

28.

Jain RK. Delivery of molecular and cellular medicine to solid tumors. Microcirculation. 1997;4:1–23.CrossRefPubMed

29.

Chaplain MAJ, McDougall SR, Anderson AR. Blood flow and tumour-induced angiogenesis: dynamically adapting vascular networks. In: Jackson TL, editor. Modeling Tumor Vasculature. New York: Springer; 2012. p. 167–212.CrossRef

30.

McDougall SR, Anderson ARA, Chaplain MAJ. Mathematical modelling of dynamic adaptive tumour-induced angiogenesis: clinical implications and therapeutic targeting strategies. J Theor Biol. 2006;241:564–89 [cited 2010 Jun 26].CrossRefPubMed

31.

Huang Y, Yuan J, Righi E, Kamoun WS, Ancukiewicz M, Nezivar J, et al. Vascular normalizing doses of antiangiogenic treatment reprogram the immunosuppressive tumor microenvironment and enhance immunotherapy. Proc Natl Acad Sci USA. 2012;109:17561–6 [cited 2012 Nov 4].CrossRefPubMedPubMedCentral

32.

Jain RK, Baxter LT. Mechanisms of heterogeneous distribution of monoclonal antibodies and other macromolecules in tumors: significance of elevated interstitial pressure. Cancer Res. 1988;48:7022–32.PubMed

33.

Stylianopoulos T, Soteriou K, Fukumura D, Jain RK. Cationic nanoparticles have superior transvascular flux into solid tumors: insights from a mathematical model. Ann Biomed Eng. 2013;41:68–77 [cited 2014 Jan 27].CrossRefPubMed

34.

Chauhan VP, Stylianopoulos T, Martin JD, Chen O, Kamoun WS, Bawendi MG, et al. Normalization of tumour blood vessels improves the delivery of nanomedicines in a size-dependent manner. Nat Nanotechnol. 2012;7:383–8.CrossRefPubMedPubMedCentral

35.

Sefidgar M, Raahemifar K, Bazmara H, Bazargan M, Mousavi SM, Soltani M. Effect of remodeled tumor-induced capillary network on interstitial flow in cancerous tissue. In: IEEE 2nd Middle East Conference on Biomedical Engineering; 2014. p. 212–5.

36.

Sefidgar M, Soltani M, Bazmara H, Mousavi M, Bazargan M, Elkamel A. Interstitial flow in cancerous tissue: effect of considering remodeled capillary network. J Tissue Sci Eng. 2014;4:1–8.

37.

Soltani M, Chen P. Numerical modeling of interstitial fluid flow coupled with blood flow through a remodeled solid tumor microvascular network. PLoS One. 2013;8:e67025.CrossRefPubMedPubMedCentral

38.

Soltani M. Numerical Modeling of Drug Delivery to Solid Tumor Microvasculature. PhD thesis, Chem. Eng. (Nanotechnology), Waterloo, Ontario, Canada. 2012.

39.

Anderson AR, Chaplain MA, Mcdougall S. A hybrid discrete-continuum model of tumour induced angiogenesis. In: Jackson TL, editor. Modeling Tumor Vasculature. New York: Springer; 2012. p. 105–34 [cited 2012 Nov 1].CrossRef

40.

Stephanou AS, Mcdougall SRR, Anderson ARA, Chaplain MAJ. Mathematical modelling of the influence of blood rheological properties upon adaptative tumour-induced angiogenesis. Math Comput Model. 2006;44:96–123 [cited 2011 Feb 12].CrossRef

41.

Pries AR, Secomb TW. Blood Flow in Microvascular Networks. Tuma RF, Durán WN, Ley K, editors. Direct. Second Edi. San Diego: Academic Press; 2008. p. 3–36.

42.

Pries AR, Secomb TW. Modeling structural adaptation of microcirculation. Microcirculation. 2008;15:753–64 [cited 2010 Jun 29].CrossRefPubMedPubMedCentral

43.

Soltani M, Chen P. Shape design of internal flow with minimum pressure loss. Adv Sci Lett. 2009;2:347–55.CrossRef

44.

Soltani M, Chen P. Effect of tumor shape and size on drug delivery to solid tumors. J. Biol. Eng. 2012;6:4 [cited 2012 May 4].CrossRefPubMedPubMedCentral

45.

Soltani M, Chen P. Numerical Modeling of Fluid Flow in Solid Tumors. PLoS One. 2011;6:1–15 [cited 2011 Jun 16].CrossRef

46.

Baxter LT, Jain RK. Transport of fluid and macromolecules in tumors. (II) role of heterogeneous perfusion and lymphatics. Microvasc Res. 1990;40:246–63.CrossRefPubMed

47.

Cai Y, Xu S, Wu JLQ, Cai Y, Xu S, Wu J, Long Q. Coupled modelling of tumour angiogenesis, tumour growth and blood perfusion. J Theor Biol (Elsevier). 2011;279:90–101 [cited 2012 Oct 9].CrossRef

48.

Wu J, Long Q, Xu S, Padhani AR. Study of tumor blood perfusion and its variation due to vascular normalization by anti-angiogenic therapy based on 3D angiogenic microvasculature. J. Biomech. 2009;42:712–21 [cited 2011 Jul 8].CrossRefPubMed

49.

Wu J, Xu S, Long Q, Collins MW, König CS, Zhao G, et al. Coupled modeling of blood perfusion in intravascular, interstitial spaces in tumor microvasculature. J. Biomech. 2008;41:996–1004 [cited 2010 Dec 29].CrossRefPubMed

50.

Orlanski I. A simple boundary condition for unbounded hyperbolic flows. J Comput Phys. 1976;21:251–69.CrossRef

51.

O’Reilly MS, Boehm T, Shing Y, Fukai N, Vasios G, Lane WS, et al. Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell (Elsevier). 2016;88:277–85.

52.

Boucher Y, Baxter LT, Jain RK. Interstitial pressure gradients in tissue-isolated and subcutaneous tumors: implications for therapy. Cancer Res. 1990;50:4478–84.PubMed

53.

Hompland T, Ellingsen C, Øvrebø KM, Rofstad EK. Interstitial fluid pressure and associated lymph node metastasis revealed in tumors by dynamic contrast-enhanced MRI interstitial fluid pressure and associated lymph node. Cancer Res. 2012;72:4899–908.CrossRefPubMed

54.

Backes H, Walberer M, Endepols H, Neumaier B, Graf R, Wienhard K, et al. Whiskers area as extracerebral reference tissue for quantification of rat brain metabolism using (18)F-FDG PET: application to focal cerebral ischemia. J. Nucl. Med. 2011;52:1252–60 [cited 2014 Apr 22].CrossRefPubMed

55.

Soltani M, Sefidgar M, Bazmara H, Rahmim A. Enhanced modeling of spatiotemporal distribution of PET tracers in solid tumors and estimation of transport parameters. J Nucl Med. 2015;56:1221.

56.

Soltani M, Sefidgar M, Bazmara H, Subramaniam R, Rahmim A. Effect of tumor shape and size on drug delivery. J Nucl Med. 2015;56:1220.

57.

Soltani M, Bazmara H, Sefidgar M, Subramaniam R, Rahmim A. SU-D-201-04: study on the impact of tumor shape and size on drug delivery to pancreatic tumors. Med Phys. 2015;42:3220.CrossRef

58.

Beard D, Bassingthwaighte J. Advection and diffusion of substances in biological tissues with complex vascular networks. Ann Biomed Eng (Kluwer Academic Publishers-Plenum Publishers). 2000;28:253–68.CrossRef

59.

Dash RK, Bassingthwaighte JB. Simultaneous blood-tissue exchange of oxygen, carbon dioxide, bicarbonate, and hydrogen ion. Ann Biomed Eng. 2006;34:1129–48.CrossRefPubMedPubMedCentral

60.

Bassingthwaighte JB, Raymond GM, Butterworth E, Alessio A, Caldwell JH. Multiscale modeling of metabolism, flows, and exchanges in heterogeneous organs. Ann N Y Acad Sci (Blackwell Publishing Inc). 2010;1188:111–20.CrossRef

61.

Soltani M, Sefidgar M, Bazmara H, Marcus C, Subramaniam RM, Rahmim A. Effect of tumor size on drug delivery to lung tumors. In: IEEE Nuclear Science Symposium Medical Imaging Conference. 2015.

62.

Huber PE, Bischof M, Heiland S, Peschke P, Saffrich R, Gro H, et al. Trimodal cancer treatment: beneficial effects of combined antiangiogenesis, radiation, and chemotherapy. Cancer Res. 2005;65:3643–55.CrossRefPubMed

63.

van Dongen GAMS, Poot AJ, Vugts DJ. PET imaging with radiolabeled antibodies and tyrosine kinase inhibitors: immuno-PET and TKI-PET. Tumour Biol. 2012;33:607–15 [cited 2014 Jun 9].CrossRefPubMedPubMedCentral

64.

Rahmim A, Zaidi H. PET versus SPECT: strengths, limitations and challenges. Nucl Med Commun. 2008;29:193–207.CrossRefPubMed

65.

Rahmim A, Qi J, Sossi V. Resolution modeling in PET imaging: theory, practice, benefits, and pitfalls. Med Phys. 2013;40:64301.CrossRef

66.

Choi SH, Paeng JC, Sohn C-H, Pagsisihan JR, Kim Y-J, Kim KG, et al. Correlation of 18F-FDG uptake with apparent diffusion coefficient ratio measured on standard and high b value diffusion MRI in head and neck cancer. J Nucl Med. 2011;52:1056–62 [cited 2014 Apr 18].CrossRefPubMed

67.

Er HC, Erden A, Kucuk NO, Gecim E. Correlation of minimum apparent diffusion coefficient with maximum standardized uptake on fluorodeoxyglucose PET-CT in patients with rectal adenocarcinoma. Diagn Interv Radiol. 2014;20:105–9 [cited 2014 Apr 11].PubMed

Titel: Spatiotemporal distribution modeling of PET tracer uptake in solid tumors
verfasst von: Madjid Soltani
Mostafa Sefidgar
Hossein Bazmara
Michael E. Casey
Rathan M. Subramaniam
Richard L. Wahl
Arman Rahmim
Publikationsdatum: 05.12.2016
Verlag: Springer Japan
Erschienen in: Annals of Nuclear Medicine / Ausgabe 2/2017
Print ISSN: 0914-7187
Elektronische ISSN: 1864-6433
DOI: https://doi.org/10.1007/s12149-016-1141-4

Springer Medizin

Abstract

Objective

Methods

Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2017

Improvement in automated quantitation of myocardial perfusion abnormality by using iterative reconstruction image in combination with resolution recovery, attenuation and scatter corrections for the detection of coronary artery disease

Acknowledgements to reviewers

Generating harmonized SUV within the EANM EARL accreditation program: software approach versus EARL-compliant reconstruction

Optimization of scan initiation timing after 11C-methionine administration for the diagnosis of suspected recurrent brain tumors

Regional myocardial damage and active inflammation in patients with cardiac sarcoidosis detected by non-invasive multi-modal imaging

Effect of chemotherapy on the impact of FDG-PET/CT in selection of patients for surgical resection of colorectal liver metastases: single center analysis of PET-CAM randomized trial